Alissa Bray

Title: Alissa Bray - Innovator in Gene Therapy

Introduction

Alissa Bray is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of gene therapy, particularly through her innovative work with Adeno-Associated Virus (AAV) systems. Her research focuses on the development of novel nucleic acid molecules and vectors that have the potential to advance therapeutic applications.

Latest Patents

Alissa Bray holds a patent for an "Inducible AAV system comprising cumate operator sequences." This invention relates to nucleic acid molecules, vectors, and plasmids that include AAV cap genes and rep genes. The cap and rep genes are operably associated with an inducible promoter that contains one or more cumate operator (CuO) sequences. Additionally, her invention encompasses producer and packaging cell lines that are instrumental in the production of AAV particles. She has 1 patent to her name.

Career Highlights

Alissa Bray is currently associated with Oxford Genetics Limited, where she continues to push the boundaries of genetic research. Her work has been pivotal in enhancing the understanding and application of AAV systems in therapeutic contexts.

Collaborations

Alissa collaborates with notable colleagues, including Ryan Cawood and Tom Payne, who contribute to her research endeavors and the advancement of their shared goals in the field of gene therapy.

Conclusion

Alissa Bray's innovative contributions to gene therapy through her patent on the inducible AAV system highlight her role as a leading inventor in this critical area of research. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.